Involvement of mTOR in globular adiponectin-induced generation of reactive oxygen species

Free Radical Research

Volumn 44, Issue 2, 2010, Pages 128-134

  Fujimoto, Akie ^a,b   Akifusa, Sumio ^a   Kamio, Noriaki ^a   Hirofuji, Takao ^b   Nonaka, Kazuaki ^a   Yamashita, Yoshihisa ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Adiponectin; AMPK; MTOR; Nitric oxide; Reactive oxygen species

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ADENYLATE KINASE; ADIPONECTIN; DEOXYGLUCOSE; ENZYME ACTIVATOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPONECTIN; AMINOIMIDAZOLE CARBOXAMIDE; ANDROSTADIENES; ANIMALS; CELLS, CULTURED; DEOXYGLUCOSE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; NITRIC OXIDE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PYRONES; REACTIVE OXYGEN SPECIES; RIBONUCLEOTIDES; SIROLIMUS; STRUCTURE-ACTIVITY RELATIONSHIP; THIOPHENES;

MAMMALIA; MURINAE;

EID: 74549189453     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715760903348328     Document Type: Article

References (21)

1. Trujillo ME, Scherer PE. Adiponectin - journey from an adi-pocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005;257:167-175.
2. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89.
3. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9: 5699-5704.
4. Nishida M, Funahashi T, Shimomura I. Pathophysiological signi-fi cance of adiponectin. Med Mol Morphol 2007;40:55-67.
5. Li S, Shin JJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009;302:179-188.
6. Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Wang Y. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther 2009;27:59-75.
7. Fantuzzi G. Adiponectin and infl ammation: consensus and controversy. J Allergy Clin Immunol 2008;121:326-330.
8. Memmott RM, Dennis PA. Akt-dependent and-independent mechanisms of mTOR regulation in cancer. Cell Signal 2009;21:656-664.
9. Thomson AW, Turnquist HR, Raimondi G. Immunoregula-tory functions of mTOR inhibition. Nat Rev Immunol 2009;9:324-337.
10. Hresko RC, Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 2005;280:40406-40416.
11. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phospho-rylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307:1098-1101.
12. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, Viollet B, Hardie DG, Sakamoto K. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem 2007;282: 32549-32560.
13. Yamaguchi N, Argueta JG, Masuhiro Y, Kagishita M, Nonaka K, Saito T, Hanazawa S, Yamashita Y. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 2005;579:6821-6826.
14. Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N, Yamashita Y. Regulation of globular adiponectin-induced apoptosis by reactive oxygen/nitrogen species in RAW264 macrophages. Free Radic Biol Med 2008;45:1326-1339.
15. Jin HK, Ahn SH, Yoon JW, Park JW, Lee EK, Yoo JS, Lee JC, Choi WS, Han JW. Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation. Biol Pharm Bull 2009;32:988-992.
16. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffi n JD, Sattler M. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005;105:1717-1723.
17. Barb D, Neuwirth A, Mantzoros CS, Balk SP. Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. Endocr Relat Cancer 2007;14:995-1005.
18. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Wada K, Nakagama H, Nakajima A. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 2009;34:339-344.
19. Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, Terauchi Y, Kadowaki T, Takeuchi Y, Fukumoto S, Ikeda T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006;99:196-208.
20. Cai Y, Martens GA, Hinke SA, Heimberg H, Pipeleers D, Van de Casteele M. Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation. Free Radic Biol Med 2007;42:64-78.
21. Ceolotto G, Gallo A, Papparella I, Franco L, Murphy E, Iori E, Pagnin E, Fadini GP, Albiero M, Semplicini A, Avogaro A. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 2007;27:2627-2633.